Clinical Trials- Liver

 DISEASE SITE  TITLE  PHASE  CONTACT  LOCATION
 Hepatocellular A Phase III Randomized, Double-Blind Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients with and without Vascular Invasion (CTSU E1208)  III Gladys Pierce RN
gladys.pierce@nmhs.org
402-354-5129
 Nebraska Methodist Hospital
Omaha
 Hepatocellular Phase III Randomized Study of Sorafenib (IND 69896, NSC 724772) Plus Doxorubicin Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
(HCC) (CALGB 80802)
 III

NMH: Gladys Pierce RN
gladys.pierce@nmhs.org
402-354-5129

----------------

NMC: Rose Hoyt; Deborah Meyer, RN, BGS;

(402) 559-6941

(Email)  dmeyerk@unmc.edu

----------

and

CHI: Rebecca Hadenfeldt, RN, BSN RHadenfeldt@sfmc-gi.org

P: 308-398-6783

 

 Nebraska Methodist Hospital
Omaha

 and at

Nebraska Medical Center, Omaha, NE

and at

Saint Francis Cancer Treatment Center, Grand Island, NE

 Hepatocellular  Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib in Patients with Advance Hepatocellular Carcinoma (HCC)    Rose Hoyt  Nebraska Medical Center, Omaha, NE
 Hepatoblastoma  AHEP0731, Treatment of Children with All Stages of Hepatoblastoma    Tamra Olson  Nebraska Medical Center, Omaha, NE
 Hepatocellular  

A Phase II Randomized Multicenter Placebo-Controlled Blinded Study of Sorafenib Adjuvant Therapy in High Risk Orthotopic Liver Transplant

(OLT) Recipients with Hepatocellular Carcinoma (HCC)
   Carol Carney  Nebraska Medical Center, Omaha, NE
 Wilms  Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumor (AREN0533)  (CHMC IRB#519-0307/UNMC 516-08)     Nancy Berounsky  Nebraska Medical Center, Omaha, NE
 Wilms  Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor (AREN0532) (UNMC 517-08)     Nancy Berounsky  Nebraska Medical Center, Omaha, NE

 

 

 

 

Nebraska Oncology Society
c/o Nebraska Medical Association
Sarah Dunbar
Executive Director
233 South 13th Street Suite 1200
Lincoln, NE 68508
sarahd@nebmed.org (email)
402-474-4472 (phone)
402-474-2198 (fax)

Powered by Wild Apricot Membership Software